217 related articles for article (PubMed ID: 32793975)
21. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.
Zahm AM; Hand NJ; Tsoucas DM; Le Guen CL; Baldassano RN; Friedman JR
J Crohns Colitis; 2014 Sep; 8(9):1108-17. PubMed ID: 24613022
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease.
Tang WJ; Peng KY; Tang ZF; Wang YH; Xue AJ; Huang Y
World J Gastroenterol; 2018 Dec; 24(46):5234-5245. PubMed ID: 30581272
[TBL] [Abstract][Full Text] [Related]
23. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers.
Luo S; Chen XH
Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516
[TBL] [Abstract][Full Text] [Related]
24. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
[TBL] [Abstract][Full Text] [Related]
25. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.
Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G
World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194
[TBL] [Abstract][Full Text] [Related]
26. Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
Boland K; Greener T; Kabakchiev B; Stempak J; Tessolini J; Li R; Soriano J; Croitoru K; Nguyen G; Steinhart AH; Weizman AV; Silverberg MS
Inflamm Bowel Dis; 2020 Apr; 26(5):766-773. PubMed ID: 31676891
[TBL] [Abstract][Full Text] [Related]
27. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
[TBL] [Abstract][Full Text] [Related]
28. Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics.
Guglielmi G; Crucitta S; Bertani L; Ruglioni M; Baiano Svizzero G; Ceccarelli L; Del Re M; Danesi R; Costa F; Fogli S
Inflamm Bowel Dis; 2024 Mar; 30(3):441-446. PubMed ID: 37696681
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
30. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
[TBL] [Abstract][Full Text] [Related]
31. Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab.
Fujioka S; Nakamichi I; Esaki M; Asano K; Matsumoto T; Kitazono T
J Gastroenterol Hepatol; 2014 Jun; 29(6):1207-14. PubMed ID: 24447044
[TBL] [Abstract][Full Text] [Related]
32. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
[TBL] [Abstract][Full Text] [Related]
33. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
35. Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease.
Kolho KL; Valtonen E; Rintamäki H; Savilahti E
Scand J Gastroenterol; 2012 Sep; 47(8-9):951-5. PubMed ID: 22746351
[TBL] [Abstract][Full Text] [Related]
36. Targeted
Notararigo S; Martín-Pastor M; Viñuela-Roldán JE; Quiroga A; Dominguez-Munoz JE; Barreiro-de Acosta M
J Mol Med (Berl); 2021 Sep; 99(9):1251-1264. PubMed ID: 34021361
[TBL] [Abstract][Full Text] [Related]
37. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
38. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review.
Chen WX; Ren LH; Shi RH
World J Gastrointest Pathophysiol; 2014 May; 5(2):63-70. PubMed ID: 24891977
[TBL] [Abstract][Full Text] [Related]
39. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
40. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.
Abreu-Delgado Y; Isidro RA; Torres EA; González A; Cruz ML; Isidro AA; González-Keelan CI; Medero P; Appleyard CB
World J Gastroenterol; 2016 Apr; 22(13):3581-91. PubMed ID: 27053850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
